Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Immunol ; 160(8): 3958-64, 1998 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-9558103

RESUMEN

Studies in IL-12-deficient mice established the necessity for IL-12 to generate a Th1 cytokine response that is often required for elimination of intracellular pathogens. In this study, we demonstrate that mice with a targeted disruption of the IL-12p40 and/or p35 gene effectively control liver damage induced by mouse hepatitis virus (MHV) infection, similar to wild-type animals. In contrast, MHV-infected IFN-gamma receptor-deficient (IFN-gammaR[-/-]) mice showed an increased susceptibility to coronaviral hepatitis. Surprisingly, MHV-infected mice lacking IL-12 produced a polarized Th1-type cytokine response, as evidenced by high IFN-gamma and nondetectable IL-4 production by CD4+ splenocytes and normal virus-specific serum IgG2a/IgG1 ratios. The virus-induced type 1 cytokine secretion pattern was not reversed in IL-12-deficient mice by in vivo neutralization of IFN-gamma nor in IFN-gammaR(-/-) mice receiving IL-12-neutralizing Abs. In IL-12-deficient mice, Th1-type responses were also generated upon immunization with inactivated MHV. In contrast, following immunization with keyhole limpet hemocyanin, mice lacking IL-12 mounted strongly reduced specific IgG2a and increased IgE responses, indicative of a type 2-dominated cytokine pattern. These findings demonstrate that following a virus infection, IL-12 is not essential for the generation of polarized T cell type 1 cytokine expression and associated immune responses, which is in marked contrast to nonviral systems. Our data suggest that viruses may selectively induce IFN-gamma production and Th1-type immune reactions even in the absence of IL-12.


Asunto(s)
Infecciones por Coronavirus/inmunología , Interleucina-12/deficiencia , Virus de la Hepatitis Murina , Células TH1/inmunología , Animales , Infecciones por Coronavirus/etiología , Inmunoglobulina G/biosíntesis , Interferón gamma/biosíntesis , Interleucina-12/genética , Interleucina-12/fisiología , Interleucina-4/biosíntesis , Ratones , Ratones Noqueados , Virus de la Hepatitis Murina/inmunología , Virus de la Hepatitis Murina/patogenicidad , Virus de la Hepatitis Murina/fisiología , Pruebas de Neutralización , Replicación Viral
2.
J Virol ; 71(7): 5277-86, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9188596

RESUMEN

We have characterized the 3'-most 3 kb of the genome of bovine torovirus (BoTV) strain Breda. A novel 1.2-kb gene, located between the genes for the membrane and nucleocapsid proteins, was identified. This gene, the 3'-most 0.5 kb of which is also present in the genome of the equine torovirus isolate Berne virus (BEV), codes for a class I membrane protein displaying 30% sequence identity with the hemagglutinin-esterases (HEs) of coronaviruses and influenza C viruses. Heterologous expression of the BoTV HE gene yielded a 65,000-molecular weight N-glycosylated protein displaying acetylesterase activity. Serologic evidence indicates that the HE homolog is expressed during the natural infection and represents a prominent antigen. By using an antiserum raised against residues 13 to 130 of HE, the HE protein was detected in radioiodinated, sucrose gradient-purified BoTV preparations. Formal evidence that HE is a structural protein was provided by immunoelectron microscopy. In addition to the large, 17- to 20-nm spikes, BoTV virions possess shorter surface projections (6 nm on average). We postulate that these surface projections, which are absent from the BEV virion, are composed of the BoTV HE homolog. The HE gene, which has now been demonstrated in three different virus genera, is a showpiece example of modular evolution.


Asunto(s)
Hemaglutininas Virales/metabolismo , Torovirus/enzimología , Proteínas Virales de Fusión , Proteínas Virales/metabolismo , Proteínas Estructurales Virales/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Bovinos , Línea Celular , Cricetinae , ADN Complementario , Genoma Viral , Hemaglutininas Virales/biosíntesis , Hemaglutininas Virales/química , Hemaglutininas Virales/genética , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Torovirus/genética , Proteínas Virales/biosíntesis , Proteínas Virales/química , Proteínas Virales/genética , Proteínas Estructurales Virales/biosíntesis , Proteínas Estructurales Virales/química , Proteínas Estructurales Virales/genética
4.
J Immunol ; 157(2): 815-21, 1996 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-8752933

RESUMEN

Both IL-12 and IFN-gamma have been implicated as principal inducers of type 1 immune responses required for the elimination of intracellular pathogens, such as viruses. We examined the in vivo antiviral role of both cytokines during coronavirus-induced hepatitis in a mouse hepatitis virus (MHV) model. The absence of IFN-gamma function in mice with a targeted disruption of the IFN-gamma R alpha-chain gene (IFN-gamma R -/-) resulted in increased susceptibility to coronaviral hepatitis associated with augmented viral replication and increased hepatocellular injury. The mutant mice showed a type 1 lymphokine response characterized by the normal high IFN-gamma and low IL-4 production. Unlike MHV-infected wild-type mice, however, the mutant IFN-gamma R -/- mice showed no increase in IL-12 p4O gene expression, similar to that in naive animals. IL-12 treatment failed to restore host resistance in IFN-gamma R -/- mice, but significantly protected MHV-susceptible C57BL/6 mice against lethal infection, although less than IFN-gamma treatment. Mice protected by IL-12 or IFN-gamma showed resistance against an otherwise lethal second MHV infection. Our data demonstrate that despite reduced IL-12 gene expression and defective IFN-gamma R function, virus-induced IFN-gamma production can occur. Furthermore, they emphasize the pivotal antiviral role of IFN-gamma in protection against acute coronavirus-induced hepatitis.


Asunto(s)
Antígenos CD/metabolismo , Hepatitis Viral Animal/etiología , Inmunosupresores/uso terapéutico , Interferón gamma/metabolismo , Interleucina-12/uso terapéutico , Receptores de Interferón/metabolismo , Enfermedad Aguda , Animales , Antígenos CD/genética , Secuencia de Bases , Femenino , Hepatitis Viral Animal/genética , Hepatitis Viral Animal/inmunología , Interferón gamma/farmacología , Interleucina-12/biosíntesis , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Datos de Secuencia Molecular , Receptores de Interferón/genética , Proteínas Recombinantes/farmacología , Receptor de Interferón gamma
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA